Month: April 2015

It might be hard to believe, but the US FDA, and the CDRH, doesn’t know everything. Very often it all starts with a conversation with the people there. Lots of very helpful people there. I know. Is this an opportunity… Continue Reading →

There has been, an ever increasing behind the scenes, push from Pharmacy Benefit Managers, to drive pharmaceutical prices down. Pricing, for the newer Hepatitis C therapeutics, went head to head recently, as two major players didn’t want to be left… Continue Reading →